0001415889-23-011251.txt : 20230718
0001415889-23-011251.hdr.sgml : 20230718
20230718215929
ACCESSION NUMBER: 0001415889-23-011251
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230714
FILED AS OF DATE: 20230718
DATE AS OF CHANGE: 20230718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gilliam Joseph E
CENTRAL INDEX KEY: 0001705850
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37463
FILM NUMBER: 231095480
MAIL ADDRESS:
STREET 1: C/O GLAUKOS CORPORATION
STREET 2: 229 AVENIDA FABRICANTE
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92677
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLAUKOS Corp
CENTRAL INDEX KEY: 0001192448
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 229 AVENIDA FABRICANTE
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92672
BUSINESS PHONE: 949-367-9600
MAIL ADDRESS:
STREET 1: 229 AVENIDA FABRICANTE
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92672
FORMER COMPANY:
FORMER CONFORMED NAME: GLAUKOS CORP
DATE OF NAME CHANGE: 20020925
4
1
form4-07192023_010723.xml
X0508
4
2023-07-14
0001192448
GLAUKOS Corp
GKOS
0001705850
Gilliam Joseph E
C/O GLAUKOS CORPORATION
ONE GLAUKOS WAY
ALISO VIEJO
CA
92656
false
true
false
false
PRESIDENT & COO
0
Common Stock
2023-07-14
4
M
0
19599
41.69
A
140083
D
Common Stock
2023-07-14
4
M
0
10000
30.92
A
150083
D
Common Stock
2023-07-14
4
M
0
10000
39.10
A
160083
D
Common Stock
2023-07-14
4
M
0
2500
39.10
A
162583
D
Common Stock
2023-07-14
4
S
0
42099
78.34
D
120484
D
Stock Option (Right to Buy)
41.69
2023-07-14
4
M
0
19599
0
D
2027-05-05
Common Stock
19599
117044
D
Stock Option (Right to Buy)
30.92
2023-07-14
4
M
0
10000
0
D
2028-03-14
Common Stock
10000
18437
D
Stock Option (Right to Buy)
39.10
2023-07-14
4
M
0
10000
0
D
2030-03-12
Common Stock
10000
40466
D
Includes 84,219 restricted stock units that have not yet vested or been delivered to the Reporting Person.
This trade was made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices.
This option was granted on May 5, 2017 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.
This option was granted on May 5, 2017 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.
This option was granted on March 12, 2020 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.
Diana Scherer, Attorney-in-Fact
2023-07-18